Acne and its variants

Therapy of Skin Diseases: A Worldwide Perspective on Therapeutic Approaches and Their Molecular Basis

Volumn , Issue , 2010, Pages 359-373

  Zouboulis, Christos C ^a   Abdel Naser, Mohamed Badawy ^a  

^a DESSAU MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891965894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-78814-0_34     Document Type: Chapter

References (101)

1. Kraning KK, Odland GF (1979) Prevalence, morbidity and cost of dermatologic diseases. J Invest Dermatol 73: 395-513
2. Cunliffe WJ, Gould DJ (1979) Prevalence of facial acne vul-garis in late adolescence and young adults. Brit Med J 1: 1109-1110 (Pubitemid 9153234)
3. Leyden JJ (1995) New understandings of the pathogenesis of acne. J Am Acad Dermatol 32:515-525
4. Gollnick HPM, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A (1991) Pathogenesis and pathogenesis-related treatment of acne. J Dermatol 18:489-499
5. Zouboulis CC (1999) Acne: current aspects on pathology and treatment. Dermatol Experiences 1:6-37
6. Koo J (1995) The psychological impact of acne: patients' perceptions. J Am Acad Dermatol 32:26-30
7. Cunliffe WJ, Gollnick H (2001) Acne: diagnosis and management. Martin Dunitz, London
8. Cunliffe WJ, Holland DB, Clark SM, Stables GI (2000) Comedogenesis: some new aetiological, clinical and therapeutic strategies. Brit J Dermatol 142:1084-1091 (Pubitemid 30418292)
9. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J (1994) Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehy-droepiandrosterone. Arch Dermatol 130: 308-314 (Pubitemid 24107868)
10. Schmidt JB, Spona J, Hubber J (1986) Androgen receptor in hirsutism and acne. Gynecol Obstet Invest 22:206-211 (Pubitemid 17196694)
11. Akamatsu H, Zouboulis CC, Orfanos CE (1992) Control of human sebocyte proliferation in vitro by testosterone and 5 a dihydrotestosterone is dependent on the topicalization of the sebaceous glands. J Invest Dermatol 99:509-511
12. Thiboutot D, Knaggs H, Gilliland K, Lin G (1998) activity of 5-a-reductase and 17-b-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vul-garis. Dermatology 196:38-42 (Pubitemid 28116035)
13. Akamatsu H, Komura J, Miyachi Y, Asada Y, Niwa Y (1990) Suppressive effects of linoleic acid on neutrophil oxygen metabolism and phagocytosis. J Invest Dermatol 95: 271-274 (Pubitemid 20261855)
14. Norris JF, Cunliffe WJ (1988) A histological and immuno-histochemical study of early acne lesions. Br J Dermatol 118:651-659
15. Zouboulis CC (2004) Acne and sebaceous gland function. Clin Dermatol 22:360-366 (Pubitemid 39535276)
16. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WJ, Rosenfield R (2005) What is the pathogen-esis of acne? Exp Dermatol 14:143-152
17. Abdel-Naser MB (2004) Selective cultivation of normal human sebocytes in vitro; a simple modified technique for a better cell yield. Exp Dermatol 13:562-566 (Pubitemid 39248385)
18. Vowels BR, Yang S, Leyden JJ (1995) Induction of proin-flammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158-3165
19. Kim J, Ochoa M-T, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535-1541 (Pubitemid 34809200)
20. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A, Seltmann H, Patrick S, Zouboulis CC, Kemény L (2006) Propionibacterium acnes and lipopolysaccharide induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 8:2195-2205 (Pubitemid 44335873)
21. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ (1992) Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98:895-901
22. Zouboulis CC (2001) Is acne vulgaris a genuine inflamma-tory disease? Dermatology 203:277-279 (Pubitemid 34045185)
23. Guy R, Green M, Kealey T (1996) Modeling of acne in vitro. J Invest Dermatol 106:176-182
24. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Rühl R, Chen W, Nau H, Orfanos CE (1998) The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 196:21-31 (Pubitemid 28116033)
25. Zouboulis CC, Böhm M (2004) Neuroendocrine regulation of sebocytes-a pathogenetic link between stress and acne. Exp Dermatol 13(suppl 4):31-35 (Pubitemid 39654439)
26. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D (2003) Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49:S1-S37 (Pubitemid 36791495)
27. Zouboulis CC (2000) Acne venenata und Acne cosmetica. In: Braun-Falco O, Gloor M, Korting HC (eds) Nutzen und Risiko von Kosmetika. Springer, Berlin, pp 116-123
28. Mahe A, Ly F, Aymard G, Dangou JM (2003) Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 148:493-500 (Pubitemid 36461328)
29. Orfanos CE, Adler YD, Zouboulis CC (2000) The SAHA syndrome. Horm Res 54:251-258 (Pubitemid 34701730)
30. Karvonen SL (1993) Acne fulminans: report of clinical find-ings and treatment of twenty-four patients. J Am Acad Dermatol 28:572-579
31. Jemec GB, Rasmussen I (1989) Bone lesions of acne fulmi-nans. Case report and review of the literature. J Am Acad Dermatol 20:353-357 (Pubitemid 19044387)
32. Zouboulis CC, Fimmel S, Ortmann J, Turnbull JR, Boschnakow A (2003) Sebaceous glands. In: Hoath SB, Maibach HI (eds) Neonatal skin-structure and function, 2nd edn. Marcel Dekker, New York, Basel, pp 59-88
33. Stevanovic DV (1960) Acne in infancy. Australas J Dermatol 5:224
34. Lucky AW, Biro FM, Huster GA, Morrison JA, Elder N (1991) Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol 127:210-216
35. Tindall JP (1985) Chloracne and chloracnegenes. J Am Acad Dermatol 1985(13):539-558
36. Kilgman AM, Mills OH Jr (1972) Acne cosmetica. Arch Dermatol 106:843-850
37. Plewig G, Fulton JE, Kligman AM (1970) Pomade acne. Arch Dermatol 101:580-584
38. Boutin RD, Resnick D (1989) The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. Am J Roentgenol 170:585-591
39. Dihlmann DW, SW HL (1987) Acquired hyperostosis syndrome (AHYS) sternocostoclavicular hyperostosis, pustu-lotic arthro-osteitis, SAPHO-syndrome): bone scintigraphy of the anterior chest wall. Clin Rheumatol 16:13-24
40. Smith R, Mann N, Maekelaeinen H, Roper J, Braue A, Varigos G (2008) A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 52:718-726
41. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, Willett WC, Holmes MD (2008) Milk consumption and acne in teenaged boys. J Am Acad Dermatol 58:787-793
42. Kaymak Y, Adisen E, Ilter N, Bideci A, Gurler D, Celik B (2007) Dietary glycemic index and glucose, insulin, insulinlike growth factor-I, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 57:819-823 (Pubitemid 47553080)
43. Katsabas AD, Stefanaki C, Cunliffe W (2004) Guidelines for treating acne. Clin Dermatol 22:439-444 (Pubitemid 39535288)
44. Zouboulis CC (2003) Therapie der Akne mit Antiandrogenen-Eine evidenzbasierte Übersicht. J Dtsch Dermatol Ges 1:535-546 (Pubitemid 37362253)
45. Zouboulis CC, Degitz K (2004) Androgen action on human skin-from basic research to clinical significance. Exp Dermatol 13(suppl 4):5-10 (Pubitemid 39654434)
46. Zouboulis CC (2006) Isotretinoin revisited-pluripotent effects on human sebaceous gland cells. J Invest Dermatol 126:2154-2156 (Pubitemid 44413158)
47. Zouboulis CC, Orfanos CE (2000) Retinoids. In: Millikan LE (ed) Drug therapy in dermatology. Marcel Dekker, New York, Basel, pp 171-233
48. Ellis CN, Millikan LE, Smith EB, Chalker DM, Swinyer LJ, Katz IH, Berger RS, Mills OH Jr, Baker M, Verschoore M, Loesche C (1998) Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vul-garis. Br J Dermatol 139:41-47
49. Haider A, Shaw JC (2004) Treatment of acne vulgaris. JAMA 292:726-735 (Pubitemid 39062528)
50. Bershad S, Singer GK, Parente JE, Tan MH, Sherer DW, Persaud AN, Lebwohl M (2002) Successful treatment of acne vulgaris using a new method: results of a randomized vehicle controlled trial of short contact therapy with 0.1% tazarotene gel. Arch Dermatol 138:481-489 (Pubitemid 34292500)
51. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP (1996) Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 57:20-35
52. Burkhart CG, Scheinfeld NS (2005) Benzoyl peroxide skin washes: basis, logic, effectiveness, and tolerance. Skinmed 4:370
53. Weinberg JM (2006) The utility of benzoyl peroxide in hydrophase base (Brevoxyl) in the treatment of acne vul-garis. J Drugs Dermatol 5:344-349
54. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, Swinehart JM, Schelling DJ, Klauda HC (1997) Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamy-cin gel, benzoyl gel and vehicle gel: combined results of two double blind investigations. J Am Acad Dermatol 37: 590-595 (Pubitemid 27446730)
55. Meynadier J, Alirezai M (1998) Systemic antibiotics for acne. Dermatology 196:135-139 (Pubitemid 28116061)
56. Zouboulis CC (2003) Moderne Aknetherapie. Akt Dermatol 29:49-57
57. Leyden JJ, Kaidbey K, Gans EH (1996) The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans. J Dermatol Treat 7:223-225 (Pubitemid 27042240)
58. Leyden JJ (2001) Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 15(suppl 3):51-55 (Pubitemid 34040987)
59. Orfanos CE, Zouboulis CC (1998) Oral retinoids in the treatment of seborrhoea and acne. Dermatology 196:140-147 (Pubitemid 28116062)
60. Zouboulis CC (2006) The truth behind this undeniable effi-cacy-recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology 212:99-100 (Pubitemid 43260721)
61. Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J, Fimmel S, Gouvousis P, Herwig R, Lehrach H, Zouboulis CC, Karakiulakis G (2005) Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 125:673-684
62. Layton AM, Dreno B, Gollnick HP, Zouboulis CC (2006) A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 20:773-776 (Pubitemid 44102906)
63. Layton AM, Knaggs H, Taylor J, Cunliff W (1993) Isotretinoin for acne vulgaris-10 years later: a safe and successful treatment. Br J Dermatol 129:292-296 (Pubitemid 23284001)
64. Katsabas A, Papakonstantinou A (2004) Acne: systemic treatment. Clin Dermatol 22:412-418 (Pubitemid 39535284)
65. Levine RM, Rasmussen JE (1983) Intralesional corticoster-oids in the treatment of nodulocystic acne. Arch Dermatol 119:480-481 (Pubitemid 13100112)
66. Jansen T, Plewig G (1997) Gram negative folliculitis. A complication of antibiotic therapy of acne vulgaris. 2: diagnosis and differential diagnosis-therapy. Fortschr Med 115:42-44
67. Ayers K, Sweeney SM, Wiss K (2005) Pityrosporum follicu-litis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med 159:64-67 (Pubitemid 40070645)
68. James WD, Leyden JJ (1985) Treatment of gram-negative folliculitis with isotretinoin. J Am Acad Dermatol 12: 319-324
69. Nnoruka E, Okoye O (2006) Topical steroid abuse: its use as a depigmenting agent. J Natl Med Assoc 98:934-939 (Pubitemid 43846252)
70. Brodell RT, O'Brien MJ Jr (1999) Topical corticosteroid-induced acne. Three treatment strategies to break the "addiction" cycle. Postgrad Med 106:225-226, 229
71. Schwartz RA, Janusz CA, Janniger CK (2006) Seborrheic dermatitis: an overview. Am Fam Physician 74:125-130 (Pubitemid 44049740)
72. Albrecht H, Schonfelder T (1965) Excoriative acne of young women-from the psychiatric viewpoint. Arch Klin Exp Dermatol 223:509-526
73. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum and acne: PAPA syndrome. Mayo Clin Proc 72:611-615 (Pubitemid 27330245)
74. Hjorth N, Sjolin KE, Sylvest B, Thomsen K (1972) Acne aestivalis: mallorca acne. Acta Derm Venereol 52:61-63
75. Tan HH (2003) Antibacterial therapy for acne. Am J Clin Dermatol 4:307-314
76. Elkayam O, Yaron M, Capsi D (1999) Minocycline induced autoimmune syndrome: an overview. Semin Arthritis Rheum 28:392-397 (Pubitemid 29289376)
77. Ross JI, Snelling AM. Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsabas A, Galvan Perez Del Pulgar JI, Rollman O, Torok L, Eady EA, Cove JH (2003) Antibiotic resistant acne: lessons from Europe. Br J Dermatol 48:467-478 (Pubitemid 36461325)
78. Eady AE, Cove JH, Holland KT, Cunliffe WJ (1989) Erythromycin resistant propinobacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 121:51-57 (Pubitemid 19177120)
79. Bremner JD (2003) Does isotretinoin cause depression and suicide? Psychopharmacol Bull 37:64-78
80. Zouboulis CC, Chen W, Thornton MJ, Qin K, Rosenfield RL (2007) Sexual hormones in human skin. Horm Metab Res 39:85-95 (Pubitemid 46540281)
81. 2 are active in sebaceous glands. J Mol Med 84:75-87 (Pubitemid 43099526)
82. Zouboulis CC, Nestoris S, Adler YD, Picardo M, Camera E, Orth M, Orfanos CE, Cunliffe WJ (2003) A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxyge-nase inhibitor. Arch Dermatol 139:668-670 (Pubitemid 36576390)
83. Zouboulis CC, Saborowski A, Boschnakow A (2005) Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210:36-38 (Pubitemid 39656717)
84. Thielitz A, Reinhold D, Vetter R, Lendeckel U, Kähne T, Bank U, Helmuth M, Neubert K, Faust J, Hartig R, Wrenger S, Zouboulis CC, Ansorge S, Gollnick H (2007) Inhibitors of dipeptidyl peptidase IV (DP I V, CD26) and aminopeptidase N (APN, CD13) target major pathogenetic steps in acne initiation. J Invest Dermatol 127:1042-1051 (Pubitemid 46625127)
85. Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M (2002) Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol 11:241-247 (Pubitemid 36934654)
86. Böhm M, Schiller M, Ständer S, Seltmann H, Li Z, Brzoska T, Metze D, Schiöth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA (2002) Evidence for expression of melano-cortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 118:533-539 (Pubitemid 34227173)
87. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR (2002) Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 99:7148-7153 (Pubitemid 34526270)
88. Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC (2007) Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 39:166-170 (Pubitemid 46535575)
89. Alesci S, Bornstein SR (2000) Neuroimmunoregulation of androgens in the adrenal gland and the skin. Horm Res 54: 281-286 (Pubitemid 34701734)
90. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R (1999) Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?" Ann N Y Acad Sci 885:287-311
91. Zouboulis CC (2004) The human skin as a hormone target and an endocrine gland. Hormones 3:9-26
92. Papageorgiou P, Katsabas A, Chu A (2000) Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 142:973-978 (Pubitemid 30304611)
93. Cunliffe WJ, Goulden V (2000) Phototherapy and acne vul-garis. Br J Dermatol 142:855-856
94. Pollock B, Turner D, Stringer MR, Bojar RA, Goulden V, Stables GI, Cunliffe WJ (2004) Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vul-garis: a study of clinical efficacy and mechanism of action. Br J Dermatol 151:616-622 (Pubitemid 39330886)
95. Kosaka S, Kawana S, Zouboulis CC, Hasan T, Ortel B (2006) Targeting of sebocytes by aminolevulinic acid-dependent photosensitization. Photochem Photobiol 82:453-457
96. Alster T, McMeekin T (1996) Improvement of facial acne scars by the 585 nm flashlamp-pumped pulsed dye laser. J Am Aacd Dermatol 35:79-81 (Pubitemid 26231328)
97. Walia S, Alster T (1999) Prolonged clinical and histologic effects from CO2 laser resurfacing of atrophic acne scars. Dermatol Surg 25:926-930 (Pubitemid 30021611)
98. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Li Wan Po A, O'Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC (2004) Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 364: 2188-2195 (Pubitemid 40018448)
99. Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J, Powala C, Ashley R (2003) Effects of subantimi-crobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 139:459-464 (Pubitemid 36427610)
100. Zouboulis CC, Piquero-Martin J (2003) Update and future of systemic acne treatment. Dermatology 206: 37-53 (Pubitemid 36164665)
101. Zouboulis CC, Hormonelle Antiandrogene in der aknetherapie. J Dtsch Dermatol Ges, in Press